| Literature DB >> 35091169 |
Iredia D Iyamu1, Yingzhao Zhao1, Prakash T Parvatkar1, Bracken F Roberts2, Debora R Casandra3, Lukasz Wojtas4, Dennis E Kyle5, Debopam Chakrabarti2, Roman Manetsch6.
Abstract
Malaria is a prevalent and lethal disease. The fast emergence and spread of resistance to current therapies is a major concern and the development of a novel line of therapy that could overcome, the problem of drug resistance, is imperative. Screening of a set of compounds with drug/natural product-based sub-structural motifs led to the identification of spirocyclic chroman-4-one 1 with promising antimalarial activity against the chloroquine-resistant Dd2 and chloroquine-sensitive 3D7 strains of the parasite. Extensive structure-activity and structure-property relationship studies were conducted to identify the essential features necessary for its activity and properties.Entities:
Keywords: Antimalarial; Drug resistance; Natural products; Spirocyclic chromane; Structure-activity relationship; Structure-property relationship
Mesh:
Substances:
Year: 2022 PMID: 35091169 PMCID: PMC9233738 DOI: 10.1016/j.bmc.2022.116629
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.461